Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, February 25, 2020
Sanofi plans to create a European company dedicated to the production and marketing to third parties of active pharmaceutical ingredients (APIs).
read more
Tuesday, February 25, 2020
Levadura Biotechnology has received the ISR for Levadura’s first Patent Cooperation Treaty patent application.
read more
Wednesday, February 26, 2020
Perrigo and Catalent Pharma Solutions announced the FDA has approved Perrigo’s ANDA for generic albuterol sulfate inhalation aerosol.
read more
Wednesday, February 26, 2020
The FDA is upgrading the Purple Book in phases with full search functionality for all approved biosimilar products and their reference products.
read more
Wednesday, February 26, 2020
Sun Pharmaceutical has launched Riomet ER™ in the U.S. to improve glycemic control in patients 10 years of age and older with type 2 diabetes mellitus.
read more
Thursday, February 27, 2020
Catalent announced the FDA has approved AYVAKIT for the treatment of adults with unresectable or metastatic gastrointestinal stromal tumor.
read more
Friday, February 28, 2020
Merck KGaA, Darmstadt, Germany and AMCM, Starnberg, Germany, announced a cooperation agreement on the 3D printing of tablets.
read more
Abpro announced the formation of a strategic partnership to advance two bispecific antibodies in key Asian markets including Greater China, Japan, and South Korea.
read more
Wednesday, March 04, 2020
Alopexx Oncology has entered into an exclusive license agreement with Beijing Shenogen Pharma Group to develop and commercialize DI-Leu16-IL2 in China and other parts of Asia.
read more
The FDA announced a change to the law will impact compounding of certain products beginning on March 23, 2020.
read more
Beroni announced its development of a medical solution using nanobody technology for the novel coronavirus in collaboration with Tianjin University has advanced into cytological experiments.
read more
Wednesday, March 11, 2020
International Pharmaceutical Expo (INTERPHEX) will be postponed due to the COVID-19 virus.
read more
Wednesday, March 11, 2020
The FDA and the FTC issued warning letters to seven companies for selling fraudulent COVID-19 products.
read more
Clearside Biomedical announced Arctic Vision has acquired an exclusive license for the commercialization and development of XIPERE in Greater China and South Korea.
read more
ImprimisRx has agreed to a product supply agreement with EyeCare Services Partners (ESP).
read more